|
Variables
|
n = 548
|
|---|
|
PHQ-9 score
|
4.522 ± 0.316
|
|
Demographics
|
|
Age
|
|
< = 60
|
166 (33.64%)
|
|
> 60
|
382 (66.36%)
|
|
Poverty income ratioa
|
|
Not poor
|
412 (81.50%)
|
|
Poor
|
94 (11.98%)
|
|
Education level
|
|
Below high school
|
110 (11.95%)
|
|
High school or above
|
438 (88.05%)
|
|
Married/live with partner
|
|
No
|
270 (39.83%)
|
|
Yes
|
278 (60.17%)
|
|
Serum estradiol, pg/ml
|
16.175 ± 1.981
|
|
Serum testosterone, ng/dL
|
16.507 ± 1.328
|
|
History of estrogen use
|
|
No
|
18 (4.92%)
|
|
Yes
|
267 (55.42%)
|
|
Duration of estrogen use (years)
|
10.697 ± 1.108
|
|
Comorbidities
|
|
Diabetes
|
|
No
|
411 (78.82%)
|
|
Yes
|
137 (21.18%)
|
|
CVD
|
|
No
|
439 (81.07%)
|
|
Yes
|
109 (18.93%)
|
|
Cancer history
|
|
No
|
409 (71.61%)
|
|
Yes
|
139 (28.39%)
|
|
Chronic respiratory tract disease
|
|
No
|
431 (76.40%)
|
|
Yes
|
117 (23.60%)
|
|
Arthritis
|
|
No
|
206 (34.49%)
|
|
Yes
|
342 (65.51%)
|
- Continuous variables are presented as mean ± standard error (SE); categorical variables are presented as counts (weighted percentage)
- Numbers may not add up to 100% due to missing value CVD cardiovascular disease
- aPoverty income ratio for not poor was defined as ≥ 1, and for poor was defined as < 1
